Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer
Science Advances · 17.04.2026 · 12 (16)
DOI: 10.1126/sciadv.aeb9764 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 17.04.2026. Verfasst von Changhao Zhao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Harbin Medical University Cancer Hospital, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical Uni…. Hauptthemen laut MEDLINE: Immunotherapy, Urinary Bladder Neoplasms, Nanomedicine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Key Research and Development Program of Heilongjiang, National Natural Science Foundation of China, Heilongjiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Intravesical administrations of chemotherapeutics or immune-agonist Bacillus Calmette-Guérin (BCG) are first-line treatments for non–muscle-invasive bladder cancer (NMIBC). However, while urination prevents drug retention in the bladder, the bladder mucus, epithelial barrier, and dense tumor stroma form multiple physical barriers that restrict intratumoral drug penetration. Here, we developed thiol-functionalized bacterial membrane–coated nanoparticles loaded with a chemotherapeutic agent epirubicin (EPI) for highly effective intravesical chemo-immunotherapy against bladder tumors. The surface thiol groups enabled urine-resistant adhesion to the mucin-rich bladder mucosa through dynamic disulfide bonds, as demonstrated in both mouse and human bladders. Meanwhile, we unexpectedly found that bacterial membrane components up-regulated matrix metalloproteinases (MMPs), facilitating tight junction disruption and collagen degradation, thereby enhancing nanoparticle penetration into tumors. Intratumoral delivery of EPI by such nanomedicine would induce robust immunogenic cell death (ICD), which by synergizing with the immunoadjuvant properties of the bacterial membrane can elicit tumor-specific immune responses, resulting in potent antitumor efficacy in both NMIBC and muscle-invasive bladder cancer (MIBC) mouse models. Notably, combination with immune checkpoint blockade further amplified systemic antitumor immunity, leading to complete regression of orthotopic bladder tumors and marked inhibition of distant lesions. Our unique nanomedicine platform by addressing challenges in current intravesical therapies would be highly promising for potent intravesical chemo-immunotherapy of bladder malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Urology, Harbin Medical University Cancer Hospital, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin 150001, China.
- Institute of Functional Nano and Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
- College of Pharmaceutical Science, Soochow University, Suzhou 215123, China.
- Biomedical Basic Research Center (BBRC) of Jiangsu Province, Suzhou, 215123, China.
ORCID-Profile: Changhao Zhao, Dayong Hou, Yanbin Liu, Yi Liu, Wanhai Xu, Ziqi Wang, Han Zhang, Zhuang Liu
Förderung
- Key Research and Development Program of Heilongjiang
- National Natural Science Foundation of China
- Heilongjiang Provincial Natural Science Foundation of China
- Fundo para o Desenvolvimento das Ciências e da Tecnologia
- The National Center of Technology Innovation for Biopharmaceuticals
- Jiangsu Key R&D Program (Social Development) Project
- Collaborative Innovation Center of Suzhou Nano Science and Technology, and the 111 Program from the Ministry of Education of China
- New Cornerstone Science Foundation
Zitieren
APA
Zhao, C., Hou, D., Wang, K., Chen, J., Wu, Y., Liu, N., Wang, Z., Liu, Y., Li, Y., Zhang, Z., Liu, Y., Hou, Z., Yang, X., Liu, X., Xu, W., Wang, Z., Zhang, H., & Liu, Z. (2026). Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer. Science Advances, 12(16). https://doi.org/10.1126/sciadv.aeb9764
Vancouver
Zhao C, Hou D, Wang K, Chen J, Wu Y, Liu N, et al. Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer. Science Advances. 2026;12(16). doi:10.1126/sciadv.aeb9764
BibTeX
@article{Zhao2026,
author = {Zhao, Changhao and Hou, Dayong and Wang, Kaiwei and Chen, Jianjiang and Wu, Yumin and Liu, Nanhui and Wang, Zhen and Liu, Yanbin and Li, Yaowei and Zhang, Zhishuai and Liu, Yi and Hou, Zhuyu and Yang, Xiaodan and Liu, Xiao and Xu, Wanhai and Wang, Ziqi and Zhang, Han and Liu, Zhuang},
title = {Mucoadhesive tumor-penetrating nanomedicine for intravesical chemo-immunotherapy against bladder cancer},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {16},
doi = {10.1126/sciadv.aeb9764}
}
EUVIMED